Nurse Practitioner · Little Rock, AR
NPI
1609954148
Since 2006
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1300 Centerview Dr
Little Rock, AR, 72211
Phone (501) 219-8900
Groups this clinician bills Medicare through
Medicare paid, 2024
$975K
44,163 services
Medicare patients, 2024
724
Average age 76
Drug cost, 2024
$6.9M
2,179 prescriptions
Company payments, 2025
$6,814
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Iris T Kennedy was code J0897 (injection, denosumab, 1 mg), 23,340 times for 103 patients. In total Iris T Kennedy billed 44,163 services in 100 codes, and Medicare paid $975K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-08-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 23,340 | 103 | $20.34 | $475K |
| J9155 Injection, degarelix, 1 mg | Office | 4,800 | 16 | $3.23 | $15K |
| J1952 Leuprolide injectable, camcevi, 1 mg | Office | 3,906 | 76 | $45.08 | $176K |
| 99214 Office E&M - Established | Office | 1,473 | 654 | $66.45 | $98K |
| 36415 Venipuncture Blood Collection | Office | 1,456 | 619 | $8.64 | $13K |
| 84153 Clinical Chemistry | Office | 1,306 | 605 | $17.94 | $23K |
| 81003 Clinical Chemistry | Office | 1,274 | 627 | $2.17 | $2,764 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,028 | 557 | $9.10 | $9,357 |
| 84403 Clinical Chemistry | Office | 831 | 360 | $25.04 | $21K |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 459 | 72 | $136.75 | $63K |
| A9575 Injection, gadoterate meglumine, 0.1 ml | Office | 445 | 22 | $0.09 | $40.74 |
| 80053 Clinical Chemistry | Office | 313 | 142 | $10.10 | $3,162 |
| 82306 Clinical Chemistry | Office | 267 | 189 | $28.84 | $7,700 |
| 96402 Chemotherapy Administration | Office | 267 | 145 | $18.35 | $4,899 |
| 83735 Clinical Chemistry | Office | 258 | 136 | $6.48 | $1,671 |
By year: 2022 $864K for 66,152 services; 2023 $1.2M for 75,141 services; 2024 $975K for 44,163 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,456 | 619 | $8.64 | $13K |
| 84153 Clinical Chemistry | 1,306 | 605 | $17.94 | $23K |
| 81003 Clinical Chemistry | 1,274 | 627 | $2.17 | $2,764 |
| 84403 Clinical Chemistry | 831 | 360 | $25.04 | $21K |
| 80053 Clinical Chemistry | 313 | 142 | $10.10 | $3,162 |
| 82306 Clinical Chemistry | 267 | 189 | $28.84 | $7,700 |
| 83735 Clinical Chemistry | 258 | 136 | $6.48 | $1,671 |
| 83615 Clinical Chemistry | 231 | 118 | $5.84 | $1,350 |
| 80048 Clinical Chemistry | 220 | 150 | $8.29 | $1,824 |
| 85025 Blood Count | 209 | 124 | $7.53 | $1,574 |
Medicare prescription drug claims, 2024
In 2024, the drug Iris T Kennedy prescribed most often to Medicare patients was Tamsulosin Hcl, with 373 prescriptions and refills. In total Iris T Kennedy wrote 2,179 Medicare prescriptions that cost $6.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 373 | 735 | 104 | $5,341 |
| Orgovyx Relugolix | 227 | 227 | 57 | $599K |
| Nubeqa Darolutamide | 199 | 199 | 50 | $2.6M |
| Xtandi Enzalutamide | 147 | 147 | 31 | $2.1M |
| Finasteride Generic | 102 | 208 | 29 | $937 |
| Testosterone Cypionate Generic | 95 | 117 | 17 | $2,999 |
| Abiraterone Acetate Generic | 86 | 86 | 14 | $147K |
| Gemtesa Vibegron | 81 | 115 | 27 | $55K |
| Erleada Apalutamide | 76 | 76 | 13 | $1.1M |
| Prednisone Generic | 70 | 100 | 17 | $312 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 58 | 97 | 12 | $733 |
| Alendronate Sodium Generic | 46 | 74 | 12 | $231 |
| Anastrozole Generic | 37 | 51 | Under 11 | $66.93 |
| Imipramine Hcl Generic | 37 | 51 | Under 11 | $1,027 |
| Testosterone Generic | 35 | 37 | Under 11 | $5,031 |
Brand drugs: - claims; generic drugs: 1,393 claims; opioid claims: 31.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Iris T Kennedy $6,814 ($6,814 in general payments such as food, travel and fees) from 16 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $5,325.
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 12 | $5,325 |
| Sumitomo Pharma America, Inc. 4506.T | 26 | $491 |
| Janssen Biotech, Inc. JNJ | 10 | $192 |
| Novartis Pharmaceuticals Corporation NVS | 11 | $175 |
| Accord Healthcare, Inc. | 6 | $98.26 |
| Pfizer Inc. PFE | 5 | $96.22 |
| Verity Pharmaceuticals Inc. | 4 | $86.89 |
| Dendreon Pharmaceuticals LLC | 3 | $64.55 |
| Caris MPI, Inc. | 3 | $62.42 |
| Urogen Pharma, Inc. URGN | 1 | $54.86 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.